安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Nexletol shows CLEAR benefit in cardiovascular outcome trial
New data for Esperion’s cholesterol lowering daily pill Nexletol, used when statins are not working in people at risk of a heart attack, could inject some momentum into the drug’s slow rollout
- U. S. FDA Approves Broad New Labels for NEXLETOL® and NEXLIZET . . .
U S FDA Approves Broad New Labels for NEXLETOL® and NEXLIZET® to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use
- U. S. FDA Approves Broad New Labels for NEXLETOL® and NEXLIZET . . .
ANN ARBOR, Mich , March 22, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the United States Food and Drug Administration (FDA) has approved broad new label expansions for NEXLETOL ® (bempedoic acid) Tablets and NEXLIZET ® (bempedoic acid and ezetimibe) Tablets based on positive CLEAR Outcomes data that include indications for cardiovascular risk reduction and expanded
- NEXLIZET® NEXLETOL® Other Outcomes Trial Information
The most common adverse reactions in the cardiovascular outcomes trial for bempedoic acid, a component of NEXLIZET and NEXLETOL, at an incidence of ≥2% and 0 5% greater than placebo were hyperuricemia, renal impairment, anemia, elevated liver enzymes, muscle spasms, gout, and cholelithiasis
- SGLT-2 Inhibitors in Heart Failure: A Review of Current . . .
Sodium-glucose co-transporter 2 (SGLT-2) inhibitors are the latest addition to guideline-directed medical therapy in heart failure (HF) with reduced ejection fraction with recent trials suggesting a significant reduction in adverse cardiovascular
- FDA Expands Labels for Nexletol, Nexlizet to Prevent Heart . . .
U S FDA approves broad new labels for Nexletol and Nexlizet to prevent heart attacks and cardiovascular procedures in both primary and secondary prevention patients, regardless of statin use
- 2026 Medicare Part D Step Therapy Drug List - cdphp. com
CDPHP® Medicare Advantage Part D Formulary Step Therapy Drug List
- List of SGLT-2 inhibitors (SGLT2 inhibitors) - Drugs. com
Other names: SGLT2 inhibitors, sodium-glucose cotransporter-2 inhibitors What are SGLT-2 inhibitors? SGLT-2 inhibitor is an abbreviation for sodium-glucose cotransporter-2 inhibitors SGLT-2 inhibitors are a class of medicine used to lower high blood glucose levels in people with type 2 diabetes They may also be called gliflozins
|
|
|